Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

OncoCyte Corporation OCX

Set alert

Price alert · OCX

All alert types
3.20 0.00 0.00%

At close · Jun 17

2.82 Day range 3.20

52-week range unavailable

YTD
+34.45%
1 year
+15.94%
Open
2.82
Prev close
3.20
Mkt cap
36.87M
Vol
100.56K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.82
High
3.20
Forward P/E
-1.27
Beta
0.00
Short ratio
2.59
Inst. own
50.60%
Dividend
0.00
Ex-div date
Earnings
Mar 29, 2024
50-d avg
2.73
200-d avg
2.89
1y target
4.13

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for OCX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 4.13 +28.9% upside
Target (low)
4.00
Target (mean)
4.13
Target (high)
4.25
Ratings (0m) 3 1 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OCX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%101.67K-67.6%0
Next quarter0.000.00 – 0.000.000.0%158.55K-9.9%0
Current year0.000.00 – 0.000.000.0%500.00K-66.7%0
Next year0.000.00 – 0.000.000.0%1.03M+106.4%0

Upgrades and downgrades

The latest rating changes

OCX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 9, 2024NeedhamReiteratedBuyBuy
May 16, 2024NeedhamReiteratedBuyBuy
Apr 24, 2024NeedhamMaintainedBuyBuy
Apr 17, 2024Stephens & Co.ReiteratedEqual-WeightEqual-Weight
Apr 15, 2024BenchmarkReiteratedSpeculative BuySpeculative Buy
Nov 13, 2023Piper SandlerMaintainedNeutralNeutral
Nov 9, 2023NeedhamMaintainedBuyBuy
Aug 24, 2023BenchmarkMaintainedSpeculative BuySpeculative Buy
Aug 15, 2023Piper SandlerMaintainedNeutralNeutral
Aug 10, 2023NeedhamMaintainedBuyBuy